Eli Lilly stock gains after CVS adds Zepbound to drug list
Investing.com Gold reports: Eli Lilly stock gains after CVS adds Zepbound to drug list. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Eli Lilly stock gains after CVS adds Zepbound to drug list. Full body text was unavailable at ingest time, so this brief is based on headline context.